Oct 17 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including H.B. Fuller Company, Sensient Technologies
and Tyler Technologies on Tuesday.
HIGHLIGHTS
* H.B. Fuller Company FUL.N : Baird cuts to neutral from outperform
* Sensient Technologies Corp SXT.N : Baird raises to outperform from neutral
* Tyler Technologies Inc TYL.N : Oppenheimer initiates coverage with
outperform rating
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday.
Stock entries are in alphabetical order.
* Arrowhead Pharmaceuticals Inc ARWR.O : Leerink Partners cuts target price to
$21 from $27
* BP BP.N : Piper Sandler raises target price to $45 from $40
* Campbell Soup Co CPB.N : Piper Sandler cuts target price to $44 from $50
* Centerpoint Energy Inc CNP.N : JP Morgan cuts target price to $32 from $34
* Charles Schwab Corp SCHW.N : Raymond James raises target price to $76 from
$72
* Dominion Energy Inc D.N : JP Morgan cuts target price to $49 from $55
* Edison International EIX.N : JP Morgan cuts target price to $75 from $79
* Entergy Corp ETR.N : JP Morgan cuts target price to $117 from $124
* Guaranty Bancshares Inc GNTY.N : Piper Sandler raises target price to $30
from $29
* H.B. Fuller Company FUL.N : Baird cuts to neutral from outperform
* Ionis Pharmaceuticals Inc IONS.O : Leerink Partners raises target price to
$39 from $35
* Kenvue Inc KVUE.N : HSBC cuts target price to $23 from $27
* Pfizer Inc PFE.N : Truist Securities cuts target price to $42 from $62
* PG&E Corp PCG.N : JP Morgan cuts target price to $18 from $19
* Reliance Steel & Aluminum Co RS.N : KeyBanc cuts target price to $290 from
$300
* Sempra SRE.N : JP Morgan cuts target price to $78 from $82
* Sensient Technologies Corp SXT.N : Baird raises to outperform from neutral
* Syndax Pharmaceuticals Inc SNDX.O : JP Morgan raises target price to $38 from
$36
* Tyler Technologies Inc TYL.N : Oppenheimer initiates coverage with outperform
rating
* Tyler Technologies Inc TYL.N : Oppenheimer initiates coverage with target
price $450
* Ultragenyx Pharmaceutical Inc RARE.O : Piper Sandler raises PT to $135 from
$130
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))